The Medicines (Products for Human Use) (Fees) Regulations 2016

Office-based inspectionsU.K.

This section has no associated Explanatory Memorandum

10.  The fee for an inspection comprising an office-based evaluation and risk assessment of documentation but not involving inspection of a site, in connection with the monitoring of—

(a)good manufacturing practice, good clinical practice or good pharmacovigilance practice, is £1,863 per day;

(b)good distribution practice, is £1,354 per day.